NCT04443062 2026-02-27
Bullseye
Radboud University Medical Center
Phase 2 Completed
Clinical Trials
5 trialsNCT05162573 2025-12-10
PROQURE-1
The Netherlands Cancer Institute
Phase 1 Completed
NCT03511664 2025-01-13
VISION
Endocyte
Phase 3 Completed
NCT03392428 2022-06-13
TheraP
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Completed
NCT03828838 2019-11-14
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer
Radboud University Medical Center
Phase 1/2 Completed